ON
← Back to feed
Gjallesa e Antarktidës mund të ndihmojë në zhvillimin e ilaçit të ri kundër melanomës
XK🔬 Science2 days ago

Gjallesa e Antarktidës mund të ndihmojë në zhvillimin e ilaçit të ri kundër melanomës

A study published by researchers from the University of Florida has discovered that toxins produced by a small marine organism known as 'ascidians' or sea squirts living in Antarctica could potentially aid in developing a new treatment for melanoma, one of the deadliest forms of skin cancer. The research, reported by The Guardian, indicates that these toxins have been shown to destroy melanoma cells in laboratory tests without harming healthy cells. Professor Bill Baker, a chemistry expert involved in the study, emphasized that while this is promising, the path to an approved drug is long and requires extensive testing. He noted that recent expeditions to Antarctica provided valuable insights into how bacteria within these organisms produce the toxins, bringing scientists closer to potential treatments. However, challenges remain, including the difficulty of harvesting sufficient quantities of the toxin without damaging the Antarctic ecosystem. Baker also highlighted that over half of approved drugs originate from natural substances, underscoring the significance of such discoveries.

Go to the primary sources (1)

The official sources this coverage is built on. Read them directly to bypass framing.

1 reports

Koha.net logoKoha.netIndependentCenterFactual 85Objective 752 days ago
Gjallesa e Antarktidës mund të ndihmojë në zhvillimin e ilaçit të ri kundër melanomës

A study published by researchers from the University of Florida has discovered that toxins produced by a small marine organism known as 'ascidians' or sea squirts living in Antarctica could potentially aid in developing a new treatment for melanoma, one of the deadliest forms of skin cancer. The research, reported by The Guardian, indicates that these toxins have been shown to destroy melanoma cells in laboratory tests without harming healthy cells. Professor Bill Baker, a chemistry expert involved in the study, emphasized that while this is promising, the path to an approved drug is long and requires extensive testing. He noted that recent expeditions to Antarctica provided valuable insights into how bacteria within these organisms produce the toxins, bringing scientists closer to potential treatments. However, challenges remain, including the difficulty of harvesting sufficient quantities of the toxin without damaging the Antarctic ecosystem. Baker also highlighted that over half of approved drugs originate from natural substances, underscoring the significance of such discoveries.

Bias read (Center): The article presents scientific findings without overt ideological framing. It focuses on the research process, challenges, and implications of the discovery without taking a partisan stance. The tone remains objective, emphasizing the scientific method and the need for further testing rather than a

Why these scores (Factual 85 · Objective 75): The article accurately reports the research findings from the primary source, including the use of ascidian toxins against melanoma in mice. However, it slightly simplifies the process and omits details about regulatory trials and the broader implications of the research. The tone is generally neutr

Keep the news honest.

ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €5/month.

Become a Supporter

Related stories